DataMeds AI, Inc. priced its initial public offering at $0.70 a share, offering 7,142,862 shares of common Stock, to list on the Nasdaq under the symbol MEDS. It filed a Form S-1 registration statement for an initial public offering on July 22, 2024. As of November 6, 2026, its final prospectus is on file (Form 424B4, September 29, 2025).
Sell to companies like DataMeds AI, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
DataMeds AI, Inc. filed a Form S-1 registration statement for an initial public offering on 2024-07-22. It has amended it 11 times. It filed its final prospectus on 2025-09-29, at a public offering price of $0.70 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our common stock is listed on the Nasdaq under the symbol “MEDS”.From the S-1/A filed 2026-10-09
Shares offered
We are offering 7,142,862 shares of Common Stock, together with Warrants to purchase up to 7,142,862 shares of Common Stock.From the 424B4 filed 2025-09-29
Offering price
7,142,862 shares of Common Stock, at a public offering price of $0.70 per share.From the 424B4 filed 2025-09-29
Use of proceeds
We intend to use the net proceeds from this offering for working capital and general corporate purposes, which may include operating expenses, research and development, and pending and future acquisitions.From the 424B4 filed 2025-09-29
Revenue
(ii) the last day of the fiscal year in which we have total annual gross revenues of $1.07 billion or more;From the S-1/A filed 2026-10-09
Net loss or income
The Company has a net loss of $517,599 for the year ended December 31,2023 and members’ deficit of $531,149 as of December 31, 2023.From the S-1 filed 2025-05-05
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-07-22 | Registration statement filed | S-1 |
| 2024-08-02 | Registration statement amended | S-1/A |
| 2024-09-27 | Registration statement amended | S-1/A |
| 2024-10-21 | Registration statement amended | S-1/A |
| 2024-11-06 | Registration statement amended | S-1/A |
| 2024-12-06 | Registration statement amended | S-1/A |
| 2024-12-18 | Registration statement amended | S-1/A |
| 2025-01-14 | Registration statement amended | S-1/A |
| 2025-02-21 | Final prospectus filed: the offering is priced | 424B4 |
| 2025-05-05 | Registration statement filed | S-1 |
| 2025-07-24 | Registration statement filed | S-1 |
| 2025-08-29 | Registration statement amended | S-1/A |
| 2025-09-12 | Registration statement amended | S-1/A |
| 2025-09-22 | Registration statement amended | S-1/A |
| 2025-09-29 | Final prospectus filed: the offering is priced | 424B4 |
| 2026-08-07 | Registration statement filed | S-1 |
| 2026-10-09 | Registration statement amended | S-1/A |
Check before you invest in DataMeds AI, Inc.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on DataMeds AI, Inc. and the records around it.
Also filing to list on the Nasdaq
IPO filings on the Nasdaq in Q4 2026, newest first.
- Parabolic Technologies, Inc. (Nov 2026)
Watch DataMeds AI, Inc.
Get an email when DataMeds AI, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on DataMeds AI, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on DataMeds AI, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on DataMeds AI, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for DataMeds AI, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.